BiotechTube

PRF110

Phase 2UNKNOWN
0 views this week 0 watching💤 Quiet
Interest: 21/100
21
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Post Operative Pain

Conditions

Post Operative Pain

Trial Timeline

Aug 1, 2016 → Jun 1, 2017

NCT ID
NCT02784327

About PRF110

PRF110 is a phase 2 stage product being developed by PainReform for Post Operative Pain. The current trial status is unknown. This product is registered under clinical trial identifier NCT02784327. Target conditions include Post Operative Pain.

What happened to similar drugs?

20 of 20 similar drugs in Post Operative Pain were approved

Approved (20) Terminated (1) Active (0)
✅raloxifene + PlaceboEli LillyApproved
✅QUTENZAAstellas PharmaApproved
✅Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IVEisaiApproved
✅Teriparatide + Strontium ranelateEli LillyApproved
✅Teriparatide + Zoledronic AcidEli LillyApproved
✅teriparatideEli LillyApproved
✅Teriparatide + RaloxifeneEli LillyApproved

Hype Score Breakdown

Clinical
12
Activity
4
Company
5
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02784327Phase 2UNKNOWN

Competing Products

20 competing products in Post Operative Pain

See all competitors
ProductCompanyStageHype Score
PRF110- oily solution (Ropivacaine)PainReformPhase 2
25
ENZ215 + ProliaAlkem LaboratoriesPhase 3
40
teriparatide + teriparatide + Placebo + Calcium Supplement + Vitamin D SupplementEli LillyPhase 3
40
raloxifene + PlaceboEli LillyApproved
43
MBX 1416 (INN imapextide)MBX BiosciencesPhase 2
36
MBX 1416 (Part A) + MBX 1416 (Part B) + Placebo + MBX 1416 (Part C)MBX BiosciencesPhase 1
23
teriparatide 20 micrograms/day subcutaneous + calcitonin 100 IU/day subcutaneousEli LillyPhase 3
40
teriparatide 20 micrograms/day subcutaneous + salmon calcitonin 100 IU/day subcutaneousEli LillyPhase 3
40
CT-P41 + US-licensed ProliaCelltrionPhase 3
40
LetrozoleChugai PharmaceuticalPhase 2
35
Eldecalcitol soft capsulesChugai PharmaceuticalPre-clinical
22
LetrozoleChugai PharmaceuticalPhase 2
35
LetrozoleChugai PharmaceuticalPhase 2
35
Placebo + DS-5565Daiichi SankyoPre-clinical
26
YM177 + etodolac + PlaceboAstellas PharmaPhase 3
40
QUTENZAAstellas PharmaApproved
43
QutenzaAstellas PharmaPre-clinical
26
CelecoxibAstellas PharmaPre-clinical
26
ASP8477 + PlaceboAstellas PharmaPhase 2
35
Naldemedine + PlaceboShionogiPhase 2
27